Premium Nahrungsergänzungsmittel | artgerecht

Diabetes Type 3 – Causes, Symptoms & Treatment

Diabetes Type 3 is a term used to describe insulin resistance in the brain, closely linked to Alzheimer's disease. It highlights the connection between metabolic dysfunction and neurodegeneration.

Regular tips about health Regular tips about health

Things worth knowing about "Diabetes Type 3"

Diabetes Type 3 is a term used to describe insulin resistance in the brain, closely linked to Alzheimer's disease. It highlights the connection between metabolic dysfunction and neurodegeneration.

What is Diabetes Type 3?

Diabetes Type 3 is a term used in medical research to describe a specific form of insulin resistance occurring in the brain, closely associated with the development and progression of Alzheimer's disease. The concept emerged because the brain in this condition fails to respond adequately to insulin, similar to how the body behaves in type 2 diabetes. While it is not yet an officially recognized classification by the World Health Organization (WHO), it is actively discussed in neuroscience and diabetology.

Causes

The exact causes of Diabetes Type 3 remain an active area of research. Key contributing factors include:

Brain insulin resistance: Brain cells lose their ability to respond to insulin, impairing glucose metabolism in neural tissue.
Reduced insulin signaling: A deficiency in insulin or insulin receptors in the brain negatively affects memory and cognitive function.
Chronic inflammation: Systemic and cerebral inflammatory processes can damage nerve cells over time.
Oxidative stress: Free radical damage impairs neuronal function and accelerates cognitive decline.
Genetic risk factors: Certain gene variants, such as the APOE-ε4 allele, increase the risk of both type 2 diabetes and Alzheimer's disease.
Link to Type 2 Diabetes: People with type 2 diabetes face a significantly elevated risk of developing Alzheimer's disease.

Symptoms

Since Diabetes Type 3 is closely tied to Alzheimer's disease, its symptoms resemble those of dementia:

Progressive memory loss and forgetfulness
Difficulty concentrating and spatial disorientation
Impaired problem-solving and judgment
Changes in language and communication
Personality changes and mood swings
Loss of independence in daily activities at advanced stages

Diagnosis

There is currently no standalone clinical diagnosis of Diabetes Type 3. Evaluation typically involves:

Neuropsychological testing to assess cognitive function
Neuroimaging such as MRI or PET scans to detect brain changes
Cerebrospinal fluid biomarkers (e.g., amyloid-beta, tau protein) as indicators of Alzheimer-related pathology
Blood tests for blood glucose, insulin levels, and HbA1c to identify coexisting type 2 diabetes

Treatment

Specific treatments for Diabetes Type 3 are still under investigation. Current approaches and research areas include:

Insulin therapy and insulin sensitizers: Studies are exploring whether intranasal insulin delivery can improve cognition by reaching the brain directly.
Antidiabetic medications: Drugs such as metformin and GLP-1 receptor agonists (e.g., semaglutide) are being studied for potential neuroprotective effects.
Lifestyle interventions: Regular physical activity, a Mediterranean-style diet, and weight management may reduce both dementia and diabetes risk.
Management of risk factors: Optimal control of blood sugar, blood pressure, and lipid levels is recommended.
Cognitive stimulation: Mental activity and social engagement as complementary supportive measures.

Scientific Background

The concept of Diabetes Type 3 was significantly shaped by research from Suzanne de la Monte at Brown University, who demonstrated in 2005 that insulin signaling pathways in the brains of Alzheimer's patients are severely impaired. Since then, extensive research has uncovered numerous biological links between insulin resistance and neurodegenerative disease. However, a scientific consensus on its precise definition and classification has not yet been established.

References

de la Monte SM, Wands JR. Alzheimer's disease is type 3 diabetes -- evidence reviewed. Journal of Diabetes Science and Technology. 2008;2(6):1101-1113.
World Health Organization (WHO). Dementia Fact Sheet. Geneva, 2023. Available at: https://www.who.int/news-room/fact-sheets/detail/dementia
Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nature Reviews Endocrinology. 2018;14(10):591-604.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.